We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Healthways (HWAY) Q2 Earnings Shine, Revenues Miss Mark
Read MoreHide Full Article
Healthways, Inc. reported second-quarter 2016 earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a stellar 53 cents. Notably, earnings also improved 83.9% on a year-over-year basis.
The upside was driven by a 10.2% improvement in revenues of approximately $125 million from the year-ago quarter. However, the revenue figure missed the consensus estimate by $64 million.
Quarter Details
Adjusted EBITDA advanced 9.6% year over year to $26 million in the reported quarter, compared with $23 million in the year-ago quarter. This was mainly driven by a remarkable performance by the network solutions business. By the end of 2016, management expects revenues to exceed $500 million and EBITDA margins to go beyond 20%.
Selling, general & administrative expenses (SG&A), as a percentage of revenues, decreased 280 basis points (bps) from the year-ago quarter to 8.1%. However, cost of services, as a percentage of revenues, surged 290 bps to 71.1%; depreciation expenses contracted 10 bps to 1.5%. Thus, operating margin at the company remained flat year over year.
Management expects expenses in the restructuring of the ‘corporate support infrastructure’ (IT infrastructure, separate back office, rebranding company) in the band of $5–$7 million. Annualized savings by the close of 2016 is anticipated between $14 million and $16 million.
Management also apprehends an additional expenditure of $35–$45 million for all the discontinued operations for the remainder of the year (mostly in third quarter). Additionally, the costs related to separation of ShareCare range between $4 million and $6 million.
Going ahead, Healthways is set to focus exclusively on the three business units – network solutions, SilverSneakers and Prime and Physical Medicine. The Medicare Advantage Plan is also expected to perform well under the Medicare star rating system.
Guidance Withdrawn
Based on the divestiture of the Total Population Health Services (TPHS) business unit to ShareCare, management has withdrawn its previously given financial guidance for 2016.
Zacks Rank & Other Key Picks
Currently, Healthway carries a Zacks Rank #2 (Buy).
Other favorably ranked stocks in the broader medical space are Natus Medical Inc , BioTelemetry Inc (BEAT - Free Report) and Halyard Health Inc . All the stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Healthways (HWAY) Q2 Earnings Shine, Revenues Miss Mark
Healthways, Inc. reported second-quarter 2016 earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a stellar 53 cents. Notably, earnings also improved 83.9% on a year-over-year basis.
The upside was driven by a 10.2% improvement in revenues of approximately $125 million from the year-ago quarter. However, the revenue figure missed the consensus estimate by $64 million.
Quarter Details
Adjusted EBITDA advanced 9.6% year over year to $26 million in the reported quarter, compared with $23 million in the year-ago quarter. This was mainly driven by a remarkable performance by the network solutions business. By the end of 2016, management expects revenues to exceed $500 million and EBITDA margins to go beyond 20%.
Selling, general & administrative expenses (SG&A), as a percentage of revenues, decreased 280 basis points (bps) from the year-ago quarter to 8.1%. However, cost of services, as a percentage of revenues, surged 290 bps to 71.1%; depreciation expenses contracted 10 bps to 1.5%. Thus, operating margin at the company remained flat year over year.
Management expects expenses in the restructuring of the ‘corporate support infrastructure’ (IT infrastructure, separate back office, rebranding company) in the band of $5–$7 million. Annualized savings by the close of 2016 is anticipated between $14 million and $16 million.
Management also apprehends an additional expenditure of $35–$45 million for all the discontinued operations for the remainder of the year (mostly in third quarter). Additionally, the costs related to separation of ShareCare range between $4 million and $6 million.
HEALTHWAYS INC Price, Consensus and EPS Surprise
HEALTHWAYS INC Price, Consensus and EPS Surprise | HEALTHWAYS INC Quote
Going ahead, Healthways is set to focus exclusively on the three business units – network solutions, SilverSneakers and Prime and Physical Medicine. The Medicare Advantage Plan is also expected to perform well under the Medicare star rating system.
Guidance Withdrawn
Based on the divestiture of the Total Population Health Services (TPHS) business unit to ShareCare, management has withdrawn its previously given financial guidance for 2016.
Zacks Rank & Other Key Picks
Currently, Healthway carries a Zacks Rank #2 (Buy).
Other favorably ranked stocks in the broader medical space are Natus Medical Inc , BioTelemetry Inc (BEAT - Free Report) and Halyard Health Inc . All the stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>